The Institute of Biomedical Sciences (IBMS) has written an article taking a look at how and why the blood tubes shortage happened, the implications and if a procurement overhaul is needed.
We would welcome any feedback on the points made in the piece as part of the Procurement Working Party’s activity.
Please find the IBMS article linked here
